Cash Flows from Operating Activities | |
Net earnings | |
Adjustments to reconcile net earnings to net cash provided by operating activities: | |
Loss from discontinued operation, net of tax | |
Depreciation | 11.71M |
Amortization | 3.17M |
Share-based compensation expense | 3.07M |
Gain on sale of equity investment | |
(Gain) Loss on foreign currency remeasurements and transactions | |
Net loss on disposals of property, plant and equipment | |
Deferred income taxes | 1.52M |
Excess tax benefits from share-based compensation expense | -139K |
Earnings from equity investments | -331K |
Dividends from equity investments | |
Increase (decrease) in cash from changes in: | |
Accounts receivable | 8.28M |
Inventories | -7.55M |
Accounts payable | 8.34M |
Income taxes payable | |
Other operating net assets | -5.85M |
Net cash provided by operating activities: | |
Continuing operations | |
Discontinued operation | |
Net cash provided by operating activities | 19.51M |
Cash Flows from Investing Activities | |
Additions to property, plant and equipment | -29.99M |
Purchases of businesses, net of cash acquired | |
Investments in unconsolidated businesses | |
Proceeds from collection of notes receivable | |
Other investing activities | 145K |
Redemptions of marketable securities | |
Payments on deferred purchase price of businesses | |
Net cash (used in) provided by investing activities: | |
Continuing operations | -29.85M |
Discontinued operation | |
Net cash used in investing activities | |
Cash Flows from Financing Activities | |
Proceeds on long-term borrowings | |
Payments on long-term borrowings | -10M |
Proceeds from exercise of stock options | 1.75M |
Excess tax benefits from share-based compensation expense | |
Payments on cash earnout arrangement | |
Payments of deferred financing costs | |
Purchases of treasury stock | 0 |
Net cash provided by (used in) financing activities | 12.27M |
Effect of exchange rate changes on cash and cash equivalents | -283K |
Net increase in cash and cash equivalents | 1.65M |
Cash and Cash Equivalents at Beginning of Period | 218.45M |
Cash and Cash Equivalents at End of Period | 220.1M |
Non-cash transactions: | |
Purchase of business by issuing Common Stock of the Company | |
Purchases of business utilizing earnout consideration recorded in current and long-term liabilities |